Signagen/rAAV包装服务,中型/SL100863/

价格
面议
货号:SL100863
浏览量:127
品牌:Signagen
服务
全国联保
正品保证
正规发票
签订合同
商品描述
AAVPackagingServiceinMediumScale

Features:
-Nonpathogenicwithleastimmuneresponse.
-Excellentgenedeliveryefficiencyinmostcelltypesincludingdividingandnon-dividingorprimarycells.
-Persistenttransgeneexpression.
-MultipleSEROtypes(AAV-1,AAV-2,AAV-3,AAV-4,AAV-5,AAV-6,AAV-7,AAV-8,AAV-9,AAV-DJ/8andAAV-DJ).

ServiceDescription:
-rAAVpackagingin1xcellstack.
-rAAVpurificationviaadvanced2xCsClultra-centrifugation.
-
Desalting,filtersterilizationandAAVtitrationviaqPCR.

rAAVSerotypesWeOffer:
AAV-1,AAV-2,AAV-3,AAV-4,AAV-5,AAV-6,AAV-7,AAV-8,AAV-9,AAV-PHP.B,AAV-DJ/8andAAV-DJ.

RequiredMaterials: AAVcisplasmidcarryingyourgeneofinterest(GOI),>150
µg.

TurnaroundTime:1~2weeks.

Deliverables:>0.2mLofsuperpurifiedinvivograderAAVvectorat>1E+13VG/mL*.

Weofferdiscountfornewcustomer,pleaserequestaquotewithustoday.



Figure1.AcomparisonofpurityandinfectivityofrAAVvectorsfromdifferentsourcesshowingsuperpurifiedandsuperinfectious(closetoclinicaltrialgrade)rAAVvectorpreparedviaouradvanceddoubleCsClultra-centrifugationapproach. 
A.rAAVvectors(total1E+9VGperlane) fromdifferentsourceswereresolvedonSDS-PAGEfollowedbysilverstaining. Lane1:GMPmanufacturedrAAVvectorfromCHOP;Lane2:rAAVpreparedviaouradvanced2xCsClultra-centrifugationapproach;Lane3:rAAVfromVectorCoreofBCM;Lane4:rAAVfromourcompetitor"V";Lane5:rAAVfromourcompetitor"C";Lane6:ProteinMarker.
B.SuperinfectiousrAAVvectorpreparedviaadvanceddoubleCsClultra-centrifugation. Leftpanel:rAAV9-GFP(total5E+9VG)fromourcompetitor"V"injectedtomouseeye;Rightpanel:rAAV-9-GFP(total5E+9VG)purifiedviaadvanced2xCsClultra-centrifugationinjectedtomouseeye. 


Figure2.AcomparisonofinfectivityofrAAVvectorsfromdifferentsourcesshowingsuperpurifiedrAAVpreparedviaadvanceddoubleCsClultra-centrifugationapproachissuperinfectious.

rAAV1-GFP(total2E+9VG)fromdifferentsourceswereinjectedtomousemuscletissue. TheGFPfluorescencewasvisualized3weekspostinjection. A.rAAV1-GFPfromourcompetitor"V";B.rAAV1-GFPfromourpre-maderAAVsstockpurifiedviaadvanceddoubleCsClultra-centrifugation. C.QuantificationdatashowedthatoursuperpurifiedrAAV(bar2)is~9timesmoreinfectiousthanthat(bar1)preparedviaconventionalCsClultra-centrifugation.  


*Finalviralyieldmaydependonthenatureoftransgene.  

思科生物科技有限公司是美国思科生物有限公司(SignaGen Laboratories, website: www.signagen.com)在中国的一家外商独资子公司,成立于2013年6月份,位于江苏省常州市。思科生物秉承美国思科生物为客户提供一站式全方位质优价廉的基因转导解决方案,为中国客户提供高质量的DNA和siRNA转染试剂和腺病毒以及腺相关病毒的定制生产服务,迄今为止已有超过600篇世界顶级生物医学期刊引用了思科生物的产品和客户定制服务。 思科生物技术有限公司拥有大型制备型超速离心机、荧光显微镜、ABI-9700萤光PCR仪、FACS和液-质联仪等先进仪器设备和上千平方米符合GMP 标准的生产车间,BSL2实验室,SPF级动物房等,完全按照美国思科公司的标准和要求生产PolyJet, GenJet, GenJet Ver. II, GenJet Plus, LipoD293和LipoJet等DNA转染试剂以及GenMute, PepMute和PowerFect等siRNA转染产品。此外美国思科生物公司拥有的多于34,000个待包装腺病毒和腺相关病毒和多于130,000 个基因沉默shRNA数据库也将全部移植到常州思科生物有限公司,为中国的生命科学事业和科学家服务。